利奈唑胺和美罗培南治疗耳诺卡菌放线菌瘤，印度

IF 6.6 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-08-18 DOI:10.3201/eid3109.250514

Kabir Sardana, Savitha Sharath, Soumya Sachdeva, Shukla Das, Gargi Rai, Praveen Kumar Singh

{"title":"利奈唑胺和美罗培南治疗耳诺卡菌放线菌瘤，印度","authors":"Kabir Sardana, Savitha Sharath, Soumya Sachdeva, Shukla Das, Gargi Rai, Praveen Kumar Singh","doi":"10.3201/eid3109.250514","DOIUrl":null,"url":null,"abstract":"Treatment of actinomycotic mycetoma with joint involvement is challenging. We present a patient in India with mycetoma who reached complete cure and remission after linezolid and meropenem treatment with a 2-year follow-up. Clinicians should use advances in drug regimens according to subspecies variations of Nocardia and regional drug susceptibility patterns to guide therapy.","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"7 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Linezolid and Meropenem for Nocardia otitidiscaviarum Actinomycetoma, India\",\"authors\":\"Kabir Sardana, Savitha Sharath, Soumya Sachdeva, Shukla Das, Gargi Rai, Praveen Kumar Singh\",\"doi\":\"10.3201/eid3109.250514\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment of actinomycotic mycetoma with joint involvement is challenging. We present a patient in India with mycetoma who reached complete cure and remission after linezolid and meropenem treatment with a 2-year follow-up. Clinicians should use advances in drug regimens according to subspecies variations of Nocardia and regional drug susceptibility patterns to guide therapy.\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":\"7 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3109.250514\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3109.250514","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

治疗与关节累及放线菌性足菌肿是具有挑战性的。我们报告了一位印度足菌肿患者，在接受利奈唑胺和美罗培南治疗后，经过2年的随访，患者完全治愈并缓解。临床医生应根据诺卡菌的亚种变化和区域药物敏感性模式，利用药物方案的进展来指导治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Linezolid and Meropenem for Nocardia otitidiscaviarum Actinomycetoma, India

Treatment of actinomycotic mycetoma with joint involvement is challenging. We present a patient in India with mycetoma who reached complete cure and remission after linezolid and meropenem treatment with a 2-year follow-up. Clinicians should use advances in drug regimens according to subspecies variations of Nocardia and regional drug susceptibility patterns to guide therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.